Clinical Trial Update: Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This document outlines a randomized, double-blind clinical trial evaluating the safety and efficacy of recombinant human erythropoietin in amyotrophic lateral s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Recombinant human erythropoietin (erythropoietin)

Snippet

Sponsor: Hanyang University Seoul Hospital | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN